NCT07623928

Brief Summary

Supporting people with psychosis to manage their emotions using virtual reality Many people who have experienced psychosis feel overwhelmed by their emotions. Emotions get in the way of doing what matters to them. They want support to manage emotions differently. There is evidence that people with psychosis find talking therapies that teach skills for managing emotions helpful. People said it helped them to understand and manage their emotions. However, they also wanted more help to apply skills they learned to their lives. It is hard to help people to use therapy skills in real-life situations. Therapists cannot be present when the skills are needed. One solution is to use virtual reality (VR) to bridge the gap between the clinic and real-life. VR involves using a headset to see and hear a very life-like computer-generated simulation of everyday life situations. People with psychosis find VR therapies engaging and helpful. It can feel safer to try things out in VR. Guided by the feedback of people with psychosis, this research will evaluate a novel therapy to help people with psychosis manage their emotions. Face-to- face therapy will be combined with VR so that people can practice emotion regulation skills safely with "live" coaching from a therapist. This should support people to use these skills when they need them. Fifteen people with psychosis will be offered the therapy. Everyone will be asked what they think of it and complete questionnaires before and after therapy to see what impact it had on their lives. A lived experience advisory group will support all aspects of the research process.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
14mo left

Started Sep 2027

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 20, 2026

Completed
14 days until next milestone

First Posted

Study publicly available on registry

June 3, 2026

Completed
1.2 years until next milestone

Study Start

First participant enrolled

September 1, 2027

Expected
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2028

6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2028

Last Updated

June 3, 2026

Status Verified

May 1, 2026

Enrollment Period

8 months

First QC Date

May 20, 2026

Last Update Submit

May 28, 2026

Conditions

Keywords

Emotion regulationPsychosisVirtual realitySchizophrenia spectrum disordersVirtual reality exposure therapyPsychotherapyDialectical behaviour therapy

Outcome Measures

Primary Outcomes (1)

  • Difficulties in Emotion Regulation Scale 16 item version (DERS-16)

    Self reported emotion regulation difficulties

    Pre therapy, immediately after therapy, 3 month follow up

Other Outcomes (4)

  • DBT Ways of Coping Checklist - DBT Skills Subscale

    Pre therapy, immediately after therapy, follow up

  • Clinical Outcomes in Routine Evaluation-10 item version (CORE-10)

    Pre therapy, immediately after therapy, 3 month follow up

  • Goal Attainment Scaling (GAS)

    Pre therapy, immediately after therapy, 3 month follow up

  • +1 more other outcomes

Study Arms (1)

MANOEUVRE therapy

OTHER
Other: MANOEUVRE therapy

Interventions

Virtual reality assisted psychological therapy for emotion regulation difficulties

MANOEUVRE therapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Currently under the care of South London and Maudsley (SLaM) National Health Service (NHS) outpatient services.
  • Clinical diagnosis of psychosis (schizophrenia spectrum disorder) (as assessed by their clinical team)
  • Willing to have the interview audio recorded (if taking part in post therapy interview)
  • Willing and able to provide informed consent to participate in the study (as assessed by their clinical team)

You may not qualify if:

  • Clinical presentation (e.g., immediate serious risk to self) (as assessed by their clinical team)
  • History of photosensitive epilepsy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King's College London

London, Greater London, SE5 8AF, United Kingdom

Location

Related Publications (2)

  • Lawlor C, Vitoratou S, Duffy J, Cooper B, De Souza T, Le Boutillier C, Carter B, Hepworth C, Jolley S. Managing emotions in psychosis: Evaluation of a brief DBT-informed skills group for individuals with psychosis in routine community services. Br J Clin Psychol. 2022 Sep;61(3):735-756. doi: 10.1111/bjc.12359. Epub 2022 Feb 7.

    PMID: 35130354BACKGROUND
  • Lawlor C, Hepworth C, Smallwood J, Carter B, Jolley S. Self-reported emotion regulation difficulties in people with psychosis compared with non-clinical controls: A systematic literature review. Clin Psychol Psychother. 2020 Mar;27(2):107-135. doi: 10.1002/cpp.2408. Epub 2020 Feb 12.

    PMID: 31661593BACKGROUND

MeSH Terms

Conditions

Psychotic DisordersSchizophreniaEmotional Regulation

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental DisordersSelf-ControlSocial BehaviorBehavior

Study Officials

  • Professor Dame Til Wykes

    King's College London

    STUDY CHAIR
  • Professor Matteo Cella

    King's College London

    STUDY DIRECTOR
  • Dr Caroline Lawlor

    King's College London

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Professor Dame Til Wykes

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 20, 2026

First Posted

June 3, 2026

Study Start (Estimated)

September 1, 2027

Primary Completion (Estimated)

May 1, 2028

Study Completion (Estimated)

November 1, 2028

Last Updated

June 3, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will share

Individual participant data that underlie the results after deidentification

Time Frame
After publication
Access Criteria
The final anonymised study dataset will be available to other researchers at the end of the programme provided that does not compromise confidentiality.

Locations